Core Focus
Achieving successful out-licensing and commercial readiness for European and US biotech assets in China.Ideal For
Innovative biotech companies with clinical-stage assets, seeking to partner with leading Chinese pharma companies.Our Approach
We bridge the gap between global innovation and the Chinese market. By integrating Market Storytelling, Clinical Pathway Design, and Innovative Deal Structuring, we do not just secure a licensing deal—we build the foundation for your partner's commercial success. We transform China's complexity into your clear path to revenue and patient impact.Key Service Modules
1. Market Readiness & Evidence Generation: Building a compelling value narrative through KOL engagement and RWE planning.2. Clinical & Regulatory Pathway Design: Creating the fastest, most viable development plan for the China NMPA.
3. Deal Structuring & Buyer Financing Support: Designing attractive terms and facilitating financing solutions for buyers to secure board approval.
4. Negotiation & Execution: Leading the process to a successful contract signing.